Navigation Links
Steroids may Reduce Recurrence of Asthma

Giving patients a short course of corticosteroids after they have been discharged from hospital for an asthma attack reduces the chances of a relapse, a Cochrane Systematic Review has found. Giving the steroids also reduces their use of inhalers. The benefit lasts for about three weeks.

This updated finding was drawn after reviewing data in six trials that together involved 374 people.

Between 12% and 16% of people who are discharged from hospital after having an asthma attack have a relapse within two weeks. There is considerable debate about the best way of treating people who have asthma attacks, including the dose, method of delivery and timing of delivery of corticosteroids.

Our research found clear evidence that people who arrived at a hospital with acute asthma and were well enough to be discharged benefited from the addition of corticosteroid therapy, says lead author Professor Brian Rowe, who works at the University of Alberta, in Edmonton, Canada.

Our systematic review strongly supports the use of systemic corticosteroids for treatment of outpatients who leave hospital after an asthma attack, says colleague Carol Spooner.

The review, however, was not able to identify enough data to show whether there was any difference between oral or intramuscular routes of administration. This topic is the subject of a future Cochrane Systematic Review.


'"/>




Page: 1

Related medicine news :

1. Inhaled Steroids Safe & Effective for Children with Asthma
2. The Use Of Steroids for Dizziness Questioned
3. The Use Of Oral Steroids For Muscular Dystrophy Questioned
4. No Steroids for Traumatic Brain Injury
5. Steroids Effective For Treating Carpel Tunnel Syndrome
6. The Use Of Steroids After Liver Transplants Questioned
7. New Study Will The Look Into The Effects Of Synthetic Steroids
8. Abuse Of Anabolic Steroids Causes Acne In Bodybuilders
9. Aggressive Teenage Behaviour: Blame It On The Anabolic Steroids
10. Steroids administered to expectant mothers, a boon for preemie babies
11. Anabolic Steroids for Today’s Young Me
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/23/2017)... ... , ... Silicon Valley Hair Institute, the leading hair transplant center in the ... the ARTAS® hair transplant system and the younger demographic. As many younger people suffer ... methods of hair restoration. , “It can be emotionally difficult for young men and ...
(Date:9/22/2017)... ... September 22, 2017 , ... PITTSBURGH...Defibrillators are used to treat ... if one isn’t accessible in certain locations, the risk of death can be ... with this idea," said an inventor from Ridgecrest, Calif. , The MOBILE AUTOMATED ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... firm in Pennsylvania, is pleased to offer in-home and online newborn sleep ... sleep deprivation has on the body,” says company owner Courtney Zentz, a pediatric ...
(Date:9/22/2017)... ... , ... “Cursed with a Curse: The Truth about Tithing”: ... experienced when breaking free from this misconception. “Cursed with a Curse: The Truth ... by Christian Faith Publishing, Lysa M. Harrison’s new book is a powerful and ...
(Date:9/22/2017)... Francisco, CA (PRWEB) , ... September 22, 2017 ... ... way to help you brush more effectively even on the go. Their electric ... like gingivitis and gum inflammation, with UV sanitizing technology. Combining leading edge Enke ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... , Sept. 7, 2017 NuvoAir (formerly ... Spirometer, announced today a partnership with Novartis Pharma AG to ... NuvoAir,s position as the leading mobile spirometry platform and Novartis, ... ... ...
(Date:9/6/2017)... -- Robert G. Szewc, M.D., is recognized by Continental Who,s ... his contributions to the Medical field.      ... practice of Kidney and Hypertension Specialists, which specializes in ... He has worked in this position since 2002, and ... as expertise in kidneys, hypertension, chronic disease and anemia, ...
(Date:9/6/2017)... 2017 NeuroRx, a clinical stage biopharma company developing ... (ASIB), has been granted Fast Track status by the US ... (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). The company ... this sequential therapy targeting patients who are admitted to Emergency ... ...
Breaking Medicine Technology: